Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Stock Up ∞
The stock’s fifty day moving average is C$2.00 and its two-hundred day moving average is C$2.00. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The company has a market capitalization of C$21.54 million and a PE ratio of -12.66.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- P/E Ratio Calculation: How to Assess Stocks
- MP Materials: Rare Earth Elements Powering the EV Boom
- Upcoming IPO Stock Lockup Period, Explained
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Using the MarketBeat Dividend Yield Calculator
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
